Fingerprint
Dive into the research topics of 'Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: Combined data from 4 clinical trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically